Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor Cells
Emre Ozkumur(Massachusetts General Hospital), Mehmet Toner(Center for Cancer Research), David T. Miyamoto(Broad Institute), David T. Ting(Massachusetts General Hospital), Anya M. Kimura(Harvard University), David N. Louis(Brigham and Women's Hospital), Bailey Morgan(Massachusetts General Hospital), James P. Sullivan(Australian National University), Ravi Kapur(Harvard University), Jordan C. Ciciliano(Georgia Institute of Technology), Aditya Bardia(UCLA Health), Daniel A. Haber(Howard Hughes Medical Institute), Min Yu(Howard Hughes Medical Institute), Richard J. Lee(La Roche College), Kyle C. Smith(Massachusetts General Hospital), Pin-i Chen(Massachusetts General Hospital), Elena F. Brachtel(University of Miami Hospital), Shyamala Maheswaran(Massachusetts General Hospital), Shannon L. Stott(Shriners Hospitals for Children - Erie), Lecia V. Sequist(Harvard University), Julie Trautwein(Harvard University), Alice T. Shaw(Dana-Farber Cancer Institute), Ajay M. Shah(University of Wales), Xi Luo(Harvard University), John R. Walsh(Massachusetts General Hospital), Sudarshana Sengupta(Harvard University), Philipp S. Spuhler(Massachusetts General Hospital), Thomas A. Barber(Massachusetts General Hospital), Benjamin L. Emmink(Massachusetts General Hospital)
Cited by 1,079
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
The 2007 WHO Classification of Tumours of the Central Nervous System
|Acta Neuropathologica|2007|4.6k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k